Tau structure: from cryo-EM to imaging
13:30-13:50 Michel Goedert (LMB-MRC, Cambridge) Structures of aggregated tau conformers
13:50-14:10 Eckhard Mandelkow (DZNE, Bonn) Structural constraints on models of transcellular propagation of tauopathy
14:10-14:30 Susanne Wegmann (DZNE Berlin) The role and (mesoscale) interactions of tau phases in biology
14:30-14:50 Eva-Maria Mandelkow (DZNE, Bonn) Monitoring tau-transgenic mice treated with adenosine A1 inhibitors by PET imaging
14:50-15:05 Naruhiko Sahara (NIRS Chiba Japan) A diagnostic platform of tauopathy using multimodal imaging techniques in human and mouse
15:05-15:20 Bernard Hanseeuw (Louvain, Belgium) [18F]-MK6240 PET to image tau aggregates in AD and other tauopathies
15:20-15:35 Tiago Gil Oliveira (Braga, Portugal) MRI brain atrophy assessment in PART
15:35-16:20 Coffee break and poster
Tau structure: from aggregated species to therapy
16:20-16:40 Louise Serpell (Univ. Sussex, UK) Tau assembly as a rational target for therapy
16:40-17:00 Leonard Petrucelli (Mayo Clinic, FL, USA) Title to come
17:00-17:20 Gail Johnson (Univ. Rochester, NY, USA) BAG3 regulates endocytosis and tau clearance
17:20-17:40 Ronald Melki (CNRS, Fontenay aux Roses) De novo assembled and patients-derived tau strains differential binding to neurons
17:40-17:55 Wiep Scheper (Amsterdam, NL) Granulo-vacuolar degeneration bodies: active lysosomal structures induced by tau pathology
17:55-18:30 Flash talks (5x5 min)